K. Kawazoe

Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetr ahy dro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.

Y. Inada, M. Tanabe, K. Nishikawa, 1988, Japanese journal of pharmacology.

Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.

Y. Inada, M. Tanabe, Y. Shibouta, 1986, Japanese journal of pharmacology.

SYNTHESIS AND CORONARY VASODILATING ACTIVITY OF 2-SUBSTITUTED ADENOSINES

O. Miyashita, R. Marumoto, Y. Yoshioka, 1975 .

CV-4151--a potent, selective thromboxane A2 synthetase inhibitor.

K. Kato, Y. Imura, M. Tanabe, 1986, Thrombosis research.

Coronary and cardiohemodynamic effects of 2-phenylamino-adenosine (CV-1808) in anesthetized dogs and cats.

M. Yanagimoto, M. Tanabe, M. Hirata, 1980, Arzneimittel-Forschung.

Proceedings: Cardiovascular action of new adenosine analogues.

K. Kawazoe, K. Kikuchi, 1974, Japanese journal of pharmacology.

Angiotensin converting enzyme inhibitory activity and antihypertensive action of CV-3317.

Y. Oka, Y. Inada, M. Tanabe, 1983 .